- iTransfuse Online Learning
- About us
- Contact us
- Site map
We include a list of interesting reading in each iTransfuse Express. The links are all kept here. Some will be accessible by subscription, but many are free access.
|On this page
Judd WJ. Editorial - When Should Tests for Unexpected Antibodies Be Done During Pregnancy? Transfusion 2011; 51(7): 1366–1368.
Dajak S et al. Severe Hemolytic Disease of Fetus and Newborn Caused by Red Blood Cell Antibodies Undetected at First-Trimester Screening. Transfusion 2011; 51(7): 1380–1388.
Shander A et al. Appropriateness of Allogeneic Red Blood Cell Transfusion: The International Consensus Conference on Transfusion Outcomes. Transfusion Medicine Reviews 2011; 25(3): 232-246.
Apelseth TO et al. Current practice and future directions for optimization of platelet transfusions in patients with severe therapy-induced cytopenia. Blood Reviews 2011; 25(3): 113–122.
Shaz BH & Hillyer CD. Residual risk of D alloimmunization: is it time to feel safe about platelets from D+ donors? Transfusion 2011; 51(6): 1132–1135.
Cid J et al. Platelet transfusions from D+ donors to D− patients: a 10-year follow-up study of 1014 patients. Transfusion 2011; 51(6): 1163–1169.
Perseghin P. High concentration plasma-reduced plateletapheresis concentrates. Transfusion and Apheresis Science 2011; 44(3): 273-276.
Refaai MA et al. An association of ABO non-identical platelet and cryoprecipitate transfusions with altered red cell transfusion needs in surgical patients. Vox Sanguinis 2011; 101(1): 55–60.
Fuller AK et al. A Comprehensive Program to Minimize Platelet Outdating. Transfusion 2011; 51(7): 1469–1476.
Borgman MA et al. The effect of FFP:RBC ratio on morbidity and mortality in trauma patients based on transfusion prediction score. Vox Sanguinis 2011; 101(1): 44–54.
Tinmouth AT & McIntyre L. The conundrum of persistent inappropriate use of frozen plasma.
Critical Care 2011; 15: 160.
Stanworth SJ et al, the Intensive Care Study of Coagulopathy (ISOC) investigators. A national study of plasma use in critical care: clinical indications, dose and effect on prothrombin time.
Critical Care 2011; 15: R108
Levi M. Prevention and Treatment of Coagulopathy in Patients Receiving Massive Transfusions. Vox Sanguinis 2011; 101(2): 154–174.
Curry N et al. Trauma-Induced Coagulopathy—A Review of the Systematic Reviews: Is There Sufficient Evidence to Guide Clinical Transfusion Practice? Transfusion Medicine Reviews 2011; 25(3): 217-231.
Padmakumar AD & Bellamy MC. Review of current practice of blood and component transfusion: critical issues for the critically ill patient. JICS 2011; 12(2): 134-139.
Roseff SD. Neonatal transfusion practice: should our policies mature with our patients?
Transfusion 2011; 51(5): 908-913.
Court EL et al. Informed consent and patient understanding of blood transfusion. Transfusion Medicine 2011; 21(3): 183-189.
Brown CJ & Navarrete CV. Clinical Relevance of the HLA System in Blood Transfusion. Vox Sanguinis 2011; 101(2): 93–105.
Wilson K. A Framework for Applying the Precautionary Principle to Transfusion Safety. Transfusion Medicine Reviews 2011; 25(3): 177-183.
Vamvakas EC. Letter to the Editor - Purported deleterious effects of “old” versus “fresh” red blood cells: an updated meta-analysis. Transfusion 2011; 51(5): 1122-1123.
Pettilä V et al, the Blood Observational Study Investigators for the ANZICS Clinical Trials Group. Age of red blood cells and mortality in the critically ill. Critical Care 2011; 15: R116.
Lacroix J et al. The Age of Blood Evaluation (ABLE) Randomized Controlled Trial: Study Design. Transfusion Medicine Reviews 2011; 25(3): 197-205.
Napolitano LM. Blood transfusion and the lung: first do no harm? Critical Care 2011; 15:152.
King KE & Ness PM. How do we prevent transfusion-associated graft-versus-host disease in children? Transfusion 2011; 51(5): 916-920.
Vraets A et al. Transfusion-Associated Hyperkalemia. Transfusion Medicine Reviews 2011; 25(3): 184-196.
Mintz PD. Editorial - Cesium cessation? An Advantage of Pathogen Reduction Treatments. Transfusion 2011; 51(7): 1369–1376.
Fast LD et al. Inactivation of Human White Blood Cells in Platelet Products after Pathogen Reduction Technology Treatment in Comparison to Gamma Irradiation. Transfusion 2011; 51(7): 1397–1404.